CE Approval Announced for First 7T MRI Scanner
By MedImaging International staff writers Posted on 05 Sep 2017 |
Image: The new 7T Magnetom Terra MRI scanner is the first ultra-high-field MR scanner that has been approved for clinical use (Photo courtesy of Siemens Healthineers).
A major medical imaging equipment provider has announced CE Mark (Conformité Européenne) approval of a new Ultra-High-Field (UHF) 7-T MRI scanner.
The new Magnetic Resonance Imaging (MRI) scanner provides more detail for neurological, and Musculoskeletal (MSK) precision medicine applications in the clinical environment.
The Dual-Mode Magnetom Terra scanner was developed by Siemens Healthineers (Erlangen, Germany), and is intended both for clinical and research applications. According to Siemens, the scanner could potentially become a significant platform for translational research.
The scanner has a high spatial and spectral resolution, and can provide detailed insights into the human MSK system, metabolic processes in the brains, and help visualize epilepsy, Alzheimer's, Multiple Sclerosis (MS), and other neurological diseases. According to Siemens, brain lesions will be easier to identify using the higher resolution, and improved image contrast of the Magnetom Terra scanner. The Magnetom Terra scanner is currently pending US FDA 510(k) approval.
SVP and GM of the Magnetic Resonance Imaging group at Siemens Healthineers, Dr. Christoph Zindel, said, "Thanks to our long-standing commitment and experience with ultra-high-field MRI as well as our extensive innovation network of collaboration partners around the world, we are now establishing 7T imaging in the clinical routine with Magnetom Terra. Having now gained approval for clinical use, we are expanding the scope of diagnostic MRI – 15 years after 3T scanners first became established. With this new clinical field strength, we can achieve a new level of detail in anatomy and function, helping further pave the way for precision medicine. I am convinced that Magnetom Terra will help grow the footprint of 7 Tesla in research and clinical application, allowing us to further explore new territories in MRI."
The new Magnetic Resonance Imaging (MRI) scanner provides more detail for neurological, and Musculoskeletal (MSK) precision medicine applications in the clinical environment.
The Dual-Mode Magnetom Terra scanner was developed by Siemens Healthineers (Erlangen, Germany), and is intended both for clinical and research applications. According to Siemens, the scanner could potentially become a significant platform for translational research.
The scanner has a high spatial and spectral resolution, and can provide detailed insights into the human MSK system, metabolic processes in the brains, and help visualize epilepsy, Alzheimer's, Multiple Sclerosis (MS), and other neurological diseases. According to Siemens, brain lesions will be easier to identify using the higher resolution, and improved image contrast of the Magnetom Terra scanner. The Magnetom Terra scanner is currently pending US FDA 510(k) approval.
SVP and GM of the Magnetic Resonance Imaging group at Siemens Healthineers, Dr. Christoph Zindel, said, "Thanks to our long-standing commitment and experience with ultra-high-field MRI as well as our extensive innovation network of collaboration partners around the world, we are now establishing 7T imaging in the clinical routine with Magnetom Terra. Having now gained approval for clinical use, we are expanding the scope of diagnostic MRI – 15 years after 3T scanners first became established. With this new clinical field strength, we can achieve a new level of detail in anatomy and function, helping further pave the way for precision medicine. I am convinced that Magnetom Terra will help grow the footprint of 7 Tesla in research and clinical application, allowing us to further explore new territories in MRI."
Latest MRI News
- World's First Whole-Body Ultra-High Field MRI Officially Comes To Market
- World's First Sensor Detects Errors in MRI Scans Using Laser Light and Gas
- Diamond Dust Could Offer New Contrast Agent Option for Future MRI Scans
- Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods